The presence of corneal antibodies in blood sera was investigated in 130 patients by immunoblotting analysis. Sera were obtained from patients before the first keratoplasty, repeated corneal transplantation or keratoplasty of the other eye. Baseline levels of antibodies in 15 healthy blood donors served to establish a positivity threshold. Patients were divided according to diagnosis and number of keratoplasties. Corneal antigens were prepared from donor corneas not suitable for surgery. Hyperimmune sera obtained by immunization of rabbits were used as positive controls. Significant increase in corneal antibodies specific to epithelial antigens was found in patients (62.5% positive) with keratitis of microbial origin. The presence of circulating antibodies to endothelial or stromal proteins was without significant changes. Depending on the number of keratoplasties no statistical difference in corneal antibodies production was observed. The group of patients with increased anti-corneal antibodies already before transplantation had to take immunosuppressive and anti-inflammatory therapy after keratoplasty.
Introduction
The eye is an immunologically privileged organ characterized by a reduced or modified immune response, which protects the eye from inflammation and autoimmunity. Ocular immune privilege is a product of multiple anatomical, physiological and immunoregulatory processes. Ocular tissues and fluids express a wide variety of anti-inflammatory and immunosuppressive molecules, including CD95-ligand molecule, transforming growth factor-β, macrophage migration inhibitory factor, and others. Moreover, antigens entering the anterior chamber of the eye evoke a unique form of immune deviation that culminates in the antigen-specific suppression of TH1 immune responses. Finally, the intraocular milieu contains both cell membrane and soluble factors that inhibit both adaptive and innate immune systems (Niederkorn 2003) .
Antigen presenting cells play an essential role in all immune disorders. They help the immune system to detect foreign antigens, but they also play a critical role in tolerance induction to both self-and foreign antigens. Normal cornea possesses, in fact, a heterogeneous population of resident antigen presenting cells, including epithelial Langerhans cells and dendritic cells (Dana 2004 ). Thus, under certain conditions, cornea is capable of evoking an immunological response. It is evidenced by the presence of subepithelial infiltrates, keratic precipitates, epithelial and stromal keratitis. Moreover, it is apparent in corneal transplantations when an immune rejection is the major cause of corneal graft failure. Cellular immune response plays dominant role in corneal rejection but humoral response can also be involved.
Patients suffering from various corneal diseases had been immunologically investigated in order to establish sensitization to corneal antigens. Increased anti-human cornea serum antibody reactivity had been found in patients with keratoconus (Jager et al. 1994) , melting disease, uveitis (Kruit et al. 1986a) , peripheral ulcerative keratitis (John et al. 1992; Gowen et al. 2002) and/or in patients with autoimmune disorders associated with the eye such as Behcets's disease (Soylu et al. 1993; Sugita et al. 2000 ) and Wegener's granulomatosis (Reynolds et al. 1998; Gowen et al. 2002) . Indirect immunofluorescence (Kruit et al. 1986b; John et al. 1992; Jager et al. 1994; Borderie et al. 2004 ) and/or ELISA (Kruit et al. 1986b; John et al. 1992; Rober et al. 2000; Robert et al. 2005) had been used to determine circulating cornea specific antibodies in patients' sera. Immunofluorescence test had been performed on bovine or donor human corneas. Protein extracts from bovine c 2008 Institute of Molecular Biology, Slovak Academy of Sciences -Circulating cornea specific antibodies and keratoplasty 133 or human corneas had been used as antigens in ELISA. Fifty percent of the sera positive in the immunofluorescence test had been positive in the ELISA (Kruit et al. 1986b) .
The aim of our study was the characterisation of patients' serum anti-corneal antibodies using immunoblotting technique on human corneal protein extracts in patients awaiting keratoplasty. In comparison with ELISA and immunofluorescence methods, the immunoblotting technique besides antibodies reveals also the antigens that play an important role in the production of these specific antibodies.
Material and methods

Patients
One hundred and thirty patients (67 men and 63 women) with keratoplasty were included in this study. Basic information about the patients came from forms filled up by surgeons. The age of patients was in the range of 12 to 97 years (the average was 61.42 years). Blood samples were obtained shortly before keratoplasty.
Patients were divided according to diagnosis and the number of keratoplasties. Twenty of 130 patients were in the group with keratoconus, 69 patients in the group with bullous keratopathy, 16 patients with keratitis, 10 with leucoma and 15 patients with degenerative disease of the cornea. Furthermore the group of bullous keratopathy was divided into subgroups of phakic (n = 43), aphakic (n = 15) and pseudophakic (n = 11) bullous keratopathy. The group of keratitis was divided into the subgroups of viral (n = 8) and microbial (n = 8) origin. Finally, the group of leucoma was subdivided into leucoma after chemical and thermal wound (n = 6) and leucoma after physical injury (n = 4).
Regarding the number of keratoplasties: the first keratoplasty (n = 78 patients), repeated keratoplasty on the same eye (n = 36) and the second keratoplasty but on the opposite eye (n = 16).
Blood serum of 15 healthy donors (control group, 10 men and 5 women) served to establish a positivity threshold. The average donors' age was 35.4 years (in the range of 18 to 53 years). Donors as well as patients were not age-and sex-matched.
In the whole group of 130 patients, only 6 of them suffered from systemic autoimmune disease (morbus Bechterev n = 1; rheumatoid arthritis n = 5) and 2 patients had organ specific autoimmune disease (struma diffusa). Twenty patients were treated with local corticoids and cyclosporines after keratoplasty.
Biological material
Blood was centrifuged 10 minutes at 600 g. Serum was collected and stored at −20
• C until the processing. Human cadaver donor corneas that could not be used for transplantation due to morphological defects were stored in OPTISOL-GS (Bausch & Lomb, Rochester, USA) medium in the refrigerator at 4-6
• C. Endothelial cells were scraped using a surgical blade and remained stroma was cut with scissors into 1-2 mm pieces. Samples were re-suspended in a small amount of normal saline and were frozen and repeatedly thawed 3-times to disrupt the cellular membrane. Antigen extracts were clarified by centrifugation. The protein concentration in the supernatant was calculated (Kalcker's method -measuring of absorbance in UV spectrum). The concentration of proteins was adjusted to 0.75 mg/mL. For the immunization of animals, the protein solution was sterilized by filtration through the bacterial apyrogenic 0.2 µm filter (Sarstedt, Nümbrecht, Germany).
Preparation of corneal antigens
Preparation of hyperimmune sera
Two months old rabbits were used for immunization. Immunization was performed in two phases: (i) the first phase consisted of 6 doses performed in three days intervals; each dose consisted of 6-8 intradermal inoculations; and (ii) the second phase was performed two months after the first phase. Antigens were injected intravenously 7-times in three-day intervals in a 50 µg dose of proteins. One month after the last dose, the rabbits were euthanized and blood was collected via cardiac punction. Serum was prepared by blood clotting, clarified and stored at −20
• C. Rabbit hyperimmune sera were used in tests as positive controls.
Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS PAGE)
Antigen extracts containing 1% (v/v) β-mercaptoethanol were warmed up to 95
• C for 10 minutes and analyzed by SDS PAGE using Mini Protean II device (Bio-Rad, Hercules, USA). For separation 4% concentrating and 12% separation gels were used. Prestained (bromphenol blue) SDS PAGE protein molecular weight standards (20.9 kDa lysozyme, 28.5 kDa soybean trypsin inhibitor, 36.4 kDa carbonic anhydrase, 49.3 kDa ovalbumin, 74 kDa bovine serum albumin, 107 kDa phosphorylase B; Bio-Rad, Hercules, USA) were used to determine the molecular weight of the antigens.
Transfer on nitrocellulose (NC) membrane
After SDS PAGE corneal antigens were transferred in buffered solution (0.025 M Tris-HCl, 0.2 M glycine, 20% methanol, pH = 8.3) on the nitrocellulose membrane. Electrotransfer continued for 1 hour at 100 V. Free sites on nitrocellulose membrane after electrotransfer were blocked with 1% (w/v) BSA in 0.02 M Tris-HCl (pH = 7.7). After electrotransfer the membrane was cut into 3 mm strips for further use. Strips were stored at −20
Testing of antibodies to corneal antigens All tested sera were diluted 1:10 in 1% (w/v) BSA in 0.02 M Tris-HCl buffer solution (pH = 7.7). Immunoblotting strips were incubated for 2 hours with donors', patients' and hyperimmune rabbit sera, respectively. After washing, peroxidase-conjugated swine anti-human immunoglobulins (SwAHu/Ig-Px) or peroxidase-conjugated swine antirabbit immunoglobulins (Sevapharma, Prague, Czech Republic) diluted 1:2000 in Tris-HCl buffer was applied on strips for 1 hour. Diaminobenzidine tetrahydrochloride dihydrate (Bio-Rad, Hercules, USA) was used for visualization. To determine the deposits of immunoglobulins (normally present in healthy cornea) in antigenic corneal extracts only SwAHu/Ig-Px was applied on immunoblotting strips. Positive bands in these tests were compared with the bands in tested blood donors and provided a threshold of positivity in patients. 
Statistical analysis
Statistical processing and evaluation was made using software MS Excel 2000 and statistical programs Statistica Cz 6.1, Arcus Quickstat Biomedical 1.1. Results were analyzed by Fisher exact test.
Results
Electrophoresis of corneal extracts
Proteins of basic corneal layers (epithelium, stroma and endothelium) were analyzed by SDS PAGE. Their molecular weight was in the range of 20-100 kDa. Some of them were common for two or all three layers; some of them were specific for individual corneal layer.
Serum antibodies to corneal antigens
Immunoblotting analysis of human corneal epithelial extracts without patients' sera using only SwAHu/IgPx showed that proteins with molecular weight of 70 kDa and 61 kDa are fragments of immunoglobulins created from the immunoglobulins that are normally present in human cornea. These fragments were formed during the warming of corneal extracts up to 95
• C in environment of reducing agent. The same fragments of immunoglobulins as in epithelium were also found in stroma. Immunobloting analysis of endothelial proteins confirmed only 70 kDa fragment of immunoglobulin.
During the further evaluation of epithelium, stroma and endothelium cornea specific antibodies in patients' sera, it was necessary to decide if the band in the strip in position of 70 kDa originates from the fragment of immunoglobulin or from the complex antigenanticorneal antibody. The presence of band of molecular weight of 70 kDa was therefore not taken into consideration, unless the intensity of the band was higher than the intensity of the band of the strip when only SwAHu/Ig-Px was used.
The most frequent anti-corneal antibodies found in patients' sera were antibodies against epithelial antigens of molecular weight 47.5 kDa, 41.2 kDa and 40.2 kDa; antibodies against stromal antigens of molecular weight 49.3 kDa, 46.3 kDa and 44.3 kDa; and antibodies against antigens of molecular weight 45.3 kDa and 40.0 kDa in the case of endothelium.
Hyperimmune control rabbit sera contained antibodies to more corneal antigens (Fig. 1, lane 2) . Human sera of blood donors negative for the antibodies were used in further testing as a negative control (Fig. 1,  lane 3) . Most of patients positive for anti-corneal immunoglobulins had antibodies against one or two antigens (Fig. 1, lanes 4 and 5) .
In individual groups and subgroups according to the diagnosis, the percentage of patients positive for cornea specific antibodies was calculated and compared with healthy blood donors (Table 1) . In blood donors the frequency of circulating anti-corneal antibodies occurrence varied from 6.7% to 13.3%. The highest incidence of corneal antibodies against epithelial antigens (62.5%) was observed in patients with keratitis of microbial origin. This result was statistically significant (p < 0.01). Corneal antibodies to stromal antigens were most frequent in subgroup with leucoma after physical injury. The highest presence of antibodies against endothelial proteins of cornea was found in subgroup of patients with aphakic bullous keratopathy. However, these results were not significant. When all patients were summarized regardless of diagnosis, no significant differences were found in comparison with healthy blood donors.
The presence of anti-corneal antibodies in sera was analyzed also from the point of view of number of underwent keratoplasties (Table 2 ). According to our results there was no significant difference in antibodies occurrence before the first and repeated keratoplasty and keratoplasty of the opposite eye. However, the highest presence of antibodies to corneal layer antigens was observed in patients with keratoplasty of the opposite eye.
Twenty patients (one of them had systemic autoimmune disease) were considered to be risk pa- n = 15 n = 20 n = 43 n = 15 n = 11 n = 8 n = 8 n = 6 n = 4 n = 15 n = 130 a Highlighted result is statistically significant (p < 0.01) in comparison with blood donors; n = number of patients. tients because of vascularization of the cornea prior to transplantation. After keratoplasty they were treated with immunosuppressive or anti-inflammatory therapy. These patients had statistically higher incidence (p < 0.01) of epithelial antigens specific antibodies (50% positive patients) in comparison with other patients (18.2%) ( Table 3 ). There was no statistically significant difference in occurrence of antibodies against stromal or endothelial proteins. When taken into consideration the positivity for antibodies to one or more corneal layer antigens simultaneously, there was a statistically significant difference (p < 0.05) in patients of these two groups. Sixtyfive percent of risk patients with immunosuppressive and anti-inflammatory therapy had antibodies to one or more corneal layer antigens as compared with the rest of patients (36.4% positive).
Discussion
The cornea is considered as an immune-privileged organ. In specific cases when integrity and normal immunotolerance is broken, immunological response to different antigens can be evoked. The precise role of specific anti-corneal antibodies in immunology of cornea is not fully understood. IgG and IgA class antibodies were found in the central cornea, while IgM in the limbal region. The latter is restricted from the central cornea due to its large size (Heath 2002) .
Various cornea-specific antigens had been detected by ELISA method: 54 kDa -major cornea-specific antigen (Kruit et al. 1986a,b; Eype et al. 1987; John et al. 1992; Jager et al. 1994) , 70 kDa antigen (John et al. 1992) , and proteins of molecular weight of 17 kDa (Kruit et al. 1986a ) and 11 kDa (Jager et al. 1994 ). The distribution of major cornea-specific antigen is various. High concentration had been seen just above the nuclei in the basal cell layer of the corneal epithelium. The 54 kDa protein had also been detected in the keratocytes of corneal stroma and in the corneal endothelium. But it had not been detected in other parts of the eye, nor had it been found in the rat liver, kidney, spleen, lung or skeletal muscle (Eype et al. 1987) .
In our experiments the frequency of occurrence of antibodies to antigens mentioned above in patients awaiting keratoplasty was not very high. Antibodies to 54 kDa proteins were found in 5 patients (2 patients in the case of epithelial extract, 2 patients in stromal extract and 1 patient in endothelial extract). Antibodies to 70 kDa antigen of epithelial extract were found in 4 patients and of endothelial extract in 1 patient. More frequent were antibodies to proteins with molec-ular weight of 49.3, 47.5, 46.3, 45.3, 44.3, 41.2, 40 .2 and 40.0 kDa. Probably, so small differences between some antigens can represent isoforms of one antigen -protein.
Up to date, antibodies to corneal antigens with molecular weights lower than 50 kDa had not been detected by ELISA in previous papers in contrast to immunoblotting method used in our study. We suppose that these corneal proteins have antigenic nature because of the presence of antibodies in patient's sera. Otherwise we cannot exclude antibody cross-reactivity but more detailed studies are needed.
Circulating antibodies to corneal antigens may be present in patients with autoimmune diseases (especially eye concerning). They had been documented in patients with Wegener's granulomatosis (Reynolds et al. 1999; Gowen et al. 2002) , rheumatoid arthritis, in both cases especially when associated with peripheral ulcerative keratitis (John et al. 1992; Reynolds et al. 1998 ), Behcet's disease (Soylu et al. 1993) , CurgStrauss' syndrome (Gowen et al. 2002) . In our group of 130 patients only 6 of them suffered from systemic autoimmune disease. Five of them had rheumatoid arthritis and one had Bechterev's disease. Only one patient with organ non-specific autoimmune disease was positive for anti-corneal antibodies so it is difficult to compare our results with experimental findings of other authors.
According to preceding papers, the presence of antibodies to corneal antigens had also been documented in entirely corneal diseases. The patients with keratoconus (Jager et al. 1994; Rober et al. 2000) , uveitis (Kruit et al. 1986a) or peripheral ulcerative keratitis (John et al. 1992; Gowen et al. 2002) had been found significantly more often positive for corneal antibodies. Our results are in agreement with these findings. We also observed increased antibody production in correlation with corneal diseases. The most positive patients (62.5%) for the presence of antibodies to corneal epithelial antigens were in the group of keratitis with microbial origin. However, only 25% of patients with keratoconus were positive for anti-corneal antibodies.
The role of antibodies in corneal graft rejection is disputable. Clinical and experimental evidence both supports and refutes the contribution of donor-derived alloantibody in corneal allograft rejection (Rober et al. 2000; Hargrave et al. 2003) . Our results show that detection of anti-corneal antibodies before keratoplasty can be warning and help in decision for early antiinflammatory or immunosuppressive therapy before the transplantation in high-risk patients. In these patients vascularization of the cornea was observed already before the transplantation. Fifty percent of them had antibodies to corneal epithelium and more than half of them (65.0%) were positive for antibodies to at least one of three basic corneal layer-specific proteins. Shortly after keratoplasty these patients had to take immunosuppressive therapy.
According to the experimental experience (personal communication, Dr. Rosocha) it could be suitable in high-risk patients to pre-treat the corneal allograft with an immunosuppressive agent (in form of drops or gel) 24 hours before the keratoplasty in the aim to avoid its rejection. The above-mentioned procedure seems to be less aggressive and more effective for the patient than per oral application of immunosuppressive drugs.
